+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Herantis Pharma Plc (HRTIS) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Herantis Pharma Plc (Herantis Pharma) is a drug development company focused on development of regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease, Cis-UCA emulsion cream for atopic dermatitis, Cis-UCA eye drops for dry eye, and lymfactin for secondary lymphedema. Its lymfactin recovers the damaged lymph system by reconstituting lymphatic vasculature. Herantis Pharma Plc develops drug candidates through late pre-clinical and early clinical stages. The company partners with pharmaceutical and biotech companies. Herantis Pharma is headquartered in Helsinki, Finland.

Herantis Pharma Plc Key Recent Developments

Mar 02, 2018: Herantis Pharma Financial Statements Release January 1 - December 31, 2017
Sep 15, 2017: Herantis Pharma receives Life Sciences Nordic Stars Award
Aug 29, 2017: Herantis Pharma: half year financial report January 1 - June 30, 2017
May 23, 2017: Herantis Pharma granted a U.S. patent on therapeutic use of MANF
Feb 28, 2017: Herantis Pharma Financial Statements Release January 1-December 31, 2016

This comprehensive SWOT profile of Herantis Pharma Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Herantis Pharma Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Herantis Pharma Plc - Key Information
  • Herantis Pharma Plc - Overview
  • Herantis Pharma Plc - Key Employees
  • Herantis Pharma Plc - Key Employee Biographies
  • Herantis Pharma Plc - Key Operational Heads
  • Herantis Pharma Plc - Major Products and Services
  • Herantis Pharma Plc - History
  • Herantis Pharma Plc - Company Statement
  • Herantis Pharma Plc - Locations And Subsidiaries
  • Herantis Pharma Plc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Herantis Pharma Plc - Business Description
  • Herantis Pharma Plc - Corporate Strategy
  • Herantis Pharma Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Herantis Pharma Plc - Strengths
  • Herantis Pharma Plc - Weaknesses
  • Herantis Pharma Plc - Opportunities
  • Herantis Pharma Plc - Threats
  • Herantis Pharma Plc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Herantis Pharma Plc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Herantis Pharma Plc, Key Information
  • Herantis Pharma Plc, Key Ratios
  • Herantis Pharma Plc, Share Data
  • Herantis Pharma Plc, Major Products and Services
  • Herantis Pharma Plc, History
  • Herantis Pharma Plc, Key Employees
  • Herantis Pharma Plc, Key Employee Biographies
  • Herantis Pharma Plc, Key Operational Heads
  • Herantis Pharma Plc, Other Locations
  • Herantis Pharma Plc, Subsidiaries
  • Herantis Pharma Plc, Key Manufacturing facilities
  • Herantis Pharma Plc, Key Competitors
  • Herantis Pharma Plc, SWOT Analysis
  • Herantis Pharma Plc, Ratios based on current share price
  • Herantis Pharma Plc, Annual Ratios
  • Herantis Pharma Plc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Herantis Pharma Plc, Performance Chart
  • Herantis Pharma Plc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3